12866_2019_1596_MOESM2_ESM.tiff (5.76 MB)
MOESM2 of Microbial biofilm correlates with an increased antibiotic tolerance and poor therapeutic outcome in infective endocarditis
figure
posted on 2019-10-22, 19:04 authored by Enea Di Domenico, Sara Rimoldi, Ilaria Cavallo, Giovanna DâAgosto, Elisabetta Trento, Giovanni Cagnoni, Alessandro Palazzin, Cristina Pagani, Francesca Romeri, Elena De Vecchi, Monica Schiavini, Daniela Secchi, Carlo Antona, Giuliano Rizzardini, Rita Dichirico, Luigi Toma, Daniela Kovacs, Giorgia Cardinali, Maria Gallo, Maria Gismondo, Fabrizio EnsoliAdditional file 2: Comparison between the Antimicrobial susceptibility test (AST) and the Anti-Biofilm Test (ABT). Susceptibility (S) and Resistance profiles of S. aureus (N1, N2, N4 and N7), E. faecalis (N5 and N8) and S. gallolyticus (N3 and N6) clinical isolates to different antimicrobials. Classification was performed according to the European Committee on Antimicrobial Susceptibility Testing clinical breakpoint tables (EUCAST clinical breakpoint table v 9.0). Ampicillin/Sulbactam (AMP/SUL), HLG - High level gentamicin, HLS - High level streptomycin, TXP/SMX - Trimethoprim/Sulfamethoxazole. (TIFF 5897 kb)
History
Usage metrics
Categories
Keywords
Antimicrobial Susceptibility Testinginfective endocarditisN 5MOESM 2N 3Resistance profilesHigh level gentamicinAmpicillinAMPHLSHLGABTTIFF 5897 kbbreakpoint tablesASTHigh level streptomycinTrimethoprimAnti-Biofilm TestClassificationoutcomefaecaligallolyticuEUCASTantimicrobialTXPMicrobial biofilm correlatesaureusAntimicrobial susceptibility testEuropean Committeeantibiotic tolerance
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC